Gavin Willis
Overview
Explore the profile of Gavin Willis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prinsley P, Jennings B, Bhutta M, Swan D, Willis G, Philpott C
Clin Otolaryngol
. 2019 May;
44(5):826-830.
PMID: 31099479
No abstract available.
2.
Jennings B, Loke Y, Skinner J, Keane M, Chu G, Turner R, et al.
PLoS One
. 2015 Apr;
10(4):e0124893.
PMID: 25876069
[This corrects the article DOI: 10.1371/journal.pone.0078053.].
3.
Jennings B, Willis G
Cancer Lett
. 2014 Mar;
356(2 Pt A):224-30.
PMID: 24614284
Folate was identified as an essential micronutrient early in the twentieth century and anti-folate chemotherapy such as 5-fluorouracil (5-FU) has been central to the medical management of solid tumours including...
4.
Jennings B, Loke Y, Skinner J, Keane M, Chu G, Turner R, et al.
PLoS One
. 2013 Oct;
8(10):e78053.
PMID: 24167597
The potential clinical utility of genetic markers associated with response to fluoropyrimidine treatment in colorectal cancer patients remains controversial despite extensive study. Our aim was to test the clinical validity...
5.
Jennings B, Kwok C, Willis G, Matthews V, Wawruch P, Loke Y
Pharmacogenet Genomics
. 2012 Mar;
22(4):290-304.
PMID: 22388795
Objectives: Many primary studies have considered the association of polymorphisms of folate metabolism and response to 5-fluorouracil (5-FU) and capecitabine in patients with colorectal cancer. The conclusions from these studies...
6.
King M, Brima E, Dainty J, Barrett D, Wright A, Willis G, et al.
J Nutr
. 2012 Jan;
142(2):389-95.
PMID: 22223574
The fractional absorption of a stable isotope-labeled folate dose can be estimated from the subsequent short-term temporal changes in the concentration of labeled L-5-methyltetrahydrofolate (L-5-methyl-THF) in plasma using mathematical modeling....
7.
Khandanpour N, Jennings B, Armon M, Wright A, Willis G, Clark A, et al.
Angiology
. 2010 Sep;
62(2):126-33.
PMID: 20834026
The association between novel atherosclerotic risk biomarkers and severity of peripheral arterial disease (PAD) was assessed. Patients (n = 133) with PAD were recruited. Established risk biomarkers including low- and...
8.
Khandanpour N, Willis G, Meyer F, Armon M, Loke Y, Wright A, et al.
J Vasc Surg
. 2009 Jan;
49(3):711-8.
PMID: 19157768
Objective: Hyperhomocysteinaemia is associated with peripheral arterial disease (PAD). There are inter-individual variations in the metabolism of homocysteine because of genetic polymorphisms. This study analyzed the role of one polymorphism...
9.
10.
Willis G, Bardsley V, Fellows I, Lonsdale R, Wimperis J, Jennings B
BMC Gastroenterol
. 2005 Jun;
5:17.
PMID: 15929796
Background: Although most patients with hereditary haemochromatosis have HFE C282Y mutations, the lifetime risk to HFE C282Y homozygotes of developing fatal diseases such as hepatocellular carcinoma is uncertain. We have...